Exponent (NASDAQ:EXPO) Releases Quarterly Earnings Results, Beats Estimates By $0.05 EPS

Exponent (NASDAQ:EXPO) issued its quarterly earnings results on Thursday. The business services provider reported $0.60 EPS for the quarter, topping the consensus estimate of $0.55 by $0.05, FiscalAI reports. The company had revenue of $171.61 million during the quarter, compared to analysts’ expectations of $144.99 million. Exponent had a net margin of 18.07% and a return on equity of 27.94%. Exponent’s revenue was up 12.0% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.52 EPS.

Here are the key takeaways from Exponent’s conference call:

• Strong second-quarter execution: Net revenue increased 12% to $148.9 million, EBITDA rose 16% with margin expanding to 28.7%, and diluted EPS grew 15% to $0.60. Results benefited from higher utilization and a large user research engagement.
• Exponent raised its 2026 outlook, now expecting 9%–10% net revenue growth and EBITDA margins of 27.8%–28.1%; third-quarter net revenue is projected to grow 8%–10%.
• Demand for AI-enabled products is expanding Exponent’s proactive user research work across consumer electronics, wearables, medical devices, and other technologies, while reactive opportunities are growing in advanced driver-assistance systems and data-center infrastructure.
• The board authorized an additional $50 million share-repurchase capacity after $211 million of buybacks over the past 12 months, alongside $61 million in dividends; management expects more than $100 million of free cash flow in the second half of 2026.
• Management indicated that the large user research study that represented approximately 4% of second-quarter net revenue moderated late in the quarter and is expected to contribute about 2% of net revenue for the remainder of the year, while fourth-quarter utilization will face normal seasonal pressure.

Exponent Stock Performance

NASDAQ:EXPO traded up $1.54 during trading hours on Friday, hitting $66.11. The stock had a trading volume of 377,331 shares, compared to its average volume of 520,828. The business’s 50 day moving average is $59.82 and its 200-day moving average is $65.22. The company has a market cap of $3.21 billion, a price-to-earnings ratio of 30.75 and a beta of 0.72. Exponent has a one year low of $51.91 and a one year high of $81.95.

Exponent Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, September 18th. Shareholders of record on Friday, September 4th will be paid a $0.31 dividend. This represents a $1.24 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Friday, September 4th. Exponent’s dividend payout ratio is presently 57.67%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on EXPO. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Exponent in a research note on Friday, July 17th. JPMorgan Chase & Co. dropped their target price on shares of Exponent from $95.00 to $80.00 and set an “overweight” rating for the company in a research report on Friday, May 15th. Finally, UBS Group set a $72.00 price target on Exponent in a research note on Friday. Two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, Exponent has an average rating of “Moderate Buy” and an average target price of $76.00.

Exponent News Summary

Here are the key news stories impacting Exponent this week:

• Positive Sentiment: Exponent reported second-quarter earnings of $0.60 per diluted share, beating the $0.55 consensus estimate and rising from $0.52 a year earlier. Revenue reached approximately $171.6 million, exceeding expectations, while operating profit increased sharply. Exponent Reports Second Quarter 2026 Financial Results
• Positive Sentiment: Management raised its 2026 net revenue growth outlook to 9%–10%, citing expanding AI-related demand. The upgraded guidance reinforces the view that Exponent’s technical consulting and engineering expertise is benefiting from new technology spending. Exponent raises 2026 net revenue growth view
• Positive Sentiment: The board authorized a $50 million increase to Exponent’s stock-repurchase program, potentially providing additional support for earnings per share and shareholder returns. It also declared a quarterly dividend of $0.31 per share, payable September 18 to shareholders of record September 4. Exponent dividend and repurchase announcement
• Neutral Sentiment: The company’s dividend offers a modest income component, with an indicated yield of roughly 1.9%. However, the latest quarter included slightly negative operating cash flow, which investors may monitor alongside the company’s growth investments.
• Negative Sentiment: Third-party data shows substantial insider selling over the past six months, including repeated sales by Chief Executive Officer Catherine Corrigan and no reported insider purchases. These transactions may reflect compensation or diversification, but could temper sentiment at a higher valuation. The data has not been independently verified.

Insider Activity

In related news, VP Bradley A. James sold 2,000 shares of the company’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $57.47, for a total value of $114,940.00. Following the completion of the sale, the vice president owned 1,105 shares in the company, valued at $63,504.35. This represents a 64.41% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, VP Joseph Sala sold 2,066 shares of the firm’s stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $56.66, for a total value of $117,059.56. The SEC filing for this sale provides additional information. In the last three months, insiders sold 15,324 shares of company stock valued at $855,019. 1.60% of the stock is owned by company insiders.

Institutional Investors Weigh In On Exponent

Large investors have recently modified their holdings of the business. Morgan Stanley grew its position in shares of Exponent by 3.6% in the 4th quarter. Morgan Stanley now owns 1,154,210 shares of the business services provider’s stock valued at $80,172,000 after purchasing an additional 39,865 shares during the period. Dimensional Fund Advisors LP lifted its stake in Exponent by 0.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 898,615 shares of the business services provider’s stock valued at $62,419,000 after buying an additional 2,654 shares in the last quarter. First Trust Advisors LP boosted its holdings in shares of Exponent by 54.9% in the fourth quarter. First Trust Advisors LP now owns 898,343 shares of the business services provider’s stock valued at $62,399,000 after buying an additional 318,209 shares during the period. Northern Trust Corp boosted its holdings in shares of Exponent by 0.6% in the third quarter. Northern Trust Corp now owns 733,354 shares of the business services provider’s stock valued at $50,953,000 after buying an additional 4,695 shares during the period. Finally, Bank of America Corp DE increased its position in shares of Exponent by 15.9% during the second quarter. Bank of America Corp DE now owns 645,726 shares of the business services provider’s stock worth $48,242,000 after acquiring an additional 88,350 shares in the last quarter. 92.37% of the stock is currently owned by institutional investors.

About Exponent

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.